Correction

Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial (vol 41, pg 3329, 2023)

JOURNAL OF CLINICAL ONCOLOGY (2023)

Volume 41, Issue 23, Pages 3962-3962

DOI: 10.1200/JCO.23.01230

Click your name to claim this paper and add it to your profile.